Form D Explorer
ReAlta Life Sciences, Inc. · CIK 1752530

Report a data issueCitable research briefCompare issuerPrivate research collection

ReAlta Life Sciences, Inc.

CIK 1752530 · Corporation · Inc. DELAWARE · NORFOLK, Virginia · Biotechnology
Sign up to follow Sign in for contact lookup

Filing history at a glance

The two most recent stored filings share the date May 21, 2025. The filing dates alone do not show which came first. The displayed filing reports $25,000,141 offered. All 3 stored filings from May 21, 2025 to May 21, 2025 are original notices.

Filings
3
Original notices
3
Amendments
0
Activity
May 21, 2025
through May 21, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Both filings have the same date. Their sequence is unknown; directional differences are suppressed.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 21, 2025 · DMay 21, 2025 · DLater minus earlier
Reported offering amount$30,000,002$25,000,141—
Reported amount sold$29,929,943$25,000,141—
Reported investor count———
Reported minimum investment$0$0—

Earlier SEC source: 0001752530-25-000002 · Later SEC source: 0001752530-25-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · May 21, 2025

Reported offering amount
$25,000,141
Reported exemptions
Rule 506(b)
Reported amount sold
$25,000,141

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (3)